Aptorum Group’s (NASDAQ:APM) quiet period will expire on Monday, January 28th. Aptorum Group had issued 1,898,734 shares in its public offering on December 18th. The total size of the offering was $29,999,997 based on an initial share price of $15.80. During the company’s quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Shares of NASDAQ:APM opened at $14.24 on Friday.

COPYRIGHT VIOLATION WARNING: This news story was first published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.watchlistnews.com/aptorum-group-ltds-apm-quiet-period-to-end-tomorrow/2774971.html.

Aptorum Group Company Profile

Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas.

See Also: When is a capital gain realized?

Receive News & Ratings for Aptorum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptorum Group and related companies with MarketBeat.com's FREE daily email newsletter.